Please enter your search keywords!

CN

2024-05-12

Summit Dialogue | Fushine Pharmaceuticals Chairman Attends Foodaily Innovation Expo CEO Night


On the evening of May 9, 2024, Bao Jianhua, Chairman of Fushine Pharmaceuticals, was invited to participate in the Foodaily Daily Food Industry Accelerator X Daily Capital CEO Night. On the theme of "Food Industry Chain Upgrading VS Global Innovation Resources", he focused on industry development hotspots with Zeng Xin, founder of Foodaily Daily Food, Cheng Jianzu of Baishuishan Business Unit, and He Quanyun, founding partner of Junchu Capital, and discussed the future industry ecology from a global perspective!


1
Foodaily FBIC
Global Food and Beverage Innovation Conference



Foodaily FBIC Global Food and Beverage Innovation Conference (hereinafter referred to as "Innovation Expo") is a "top stage" created by Foodaily Daily Food specifically for product decision makers in the food and beverage industry, which integrates peak dialogue, innovative exploration and collision of wisdom.



This year's Innovation Expo brought together over 150 business leaders and over 4,000 brands, including Jiang Xiaobai, General Mills, Guigui Tea, Meiji Landou, Mintel, White Elephant Foods, Weilong, Want Want Foods, Kashi Dairy, Zhizhuo Butcher, and JD Health, as well as high-quality international brand resources, capital, government, and media. Focusing on the upstream and downstream of the food and beverage industry, the event engaged participants in discussions and explored the potential for deeper collaboration, connecting high-quality resources, and, with a more open attitude, building a new industrial ecosystem to drive innovation and development in the food industry.
As an important part of the CIIE, the CEO Roundtable Conference invites food and beverage giants and industry leaders to engage in in-depth exchanges and discussions around real and specific market demands and category pain points, jointly explore new paths for industry breakthroughs, and discuss the new future of the food industry!


2
Alternative protein innovation



At the CIIE, alternative proteins became a hot topic. As people's interest in healthy eating continues to grow, alternative proteins, as an emerging food ingredient, are gradually entering people's dining tables. Zhang Yangjun, Investment Director of Daofuzi, delivered an in-depth speech on the theme of "New Proteins Fire the First Shot of Food Revolution." He stated, "A healthy dietary shift involves more than doubling the consumption of healthy foods like fruits, vegetables, legumes, and nuts, while reducing global consumption of less healthy foods like sugar and red meat by more than half." The development of new proteins can both improve human health and benefit the environment.

At the roundtable meeting on "Future Food, Future Meals, How New Proteins Will Redefine Chinese People's Table Cuisine", it was mentioned that protein innovation is a crucial part of developing future food. New proteins are now widely accepted in the European market. One-third of Burger King's Royale burgers are plant-based versions. If alternative proteins want to occupy the Chinese market and enter the Chinese people's tables, they need to conform to the Chinese people's dietary structure and food culture.

The rise of alternative proteins is undeniable. More and more food service companies are incorporating them into their menus to meet consumers' demand for healthier options. At the same time, alternative proteins offer new development opportunities for food companies, driving them to innovate and develop healthier and more delicious food products.


3
microbial protein
It is a blue ocean of opportunity and potential



Fushine Pharmaceuticals, the first company in China to achieve ton-scale industrialization of fungal protein, participated in this global food and beverage industry summit for the first time. Chairman Bao Jianhua noted that microbial protein is in its infancy in China, representing a vast and promising market, poised to play a significant role in the future food and beverage industry. Through in-depth research, Fushine Pharmaceuticals has successfully developed a superior bacterial strain and a more efficient and environmentally friendly microbial protein production process. This technological breakthrough not only improves the yield and quality of microbial protein but also reduces production costs, providing strong support for the sustainable development of the industry.

Chairman Bao Jianhua said that Fushine Pharmaceuticals will continue to uphold the concept of "innovation, efficiency, greenness and sustainability", continuously promote the innovation and progress of microbial protein technology, and contribute more wisdom and strength to the sustainable development of the global food and beverage industry.



4
Fushine microbial protein



Currently, one of the company's main businesses is microbial protein, a type of alternative protein. This product utilizes synthetic biology techniques, based on a Fusarium chassis strain, using glucose and water as raw materials. This is produced through biomass fermentation technology, which involves cultivating and propagating microbial flora and using the microorganisms themselves as food products. The company already possesses a novel production strain, has applied for a patent, and has received a notice of acceptance.

The company's microbial protein is characterized by high efficiency, low consumption, sustainability and better health. It is rich in protein, high dietary fiber, low sugar, low fat, zero cholesterol, zero trans fatty acids, and contains 18 essential amino acids for the human body. It can be widely used in "artificial meat", protein drinks, snacks, health products, pet food and other fields.

Leveraging its existing software and hardware resources, the company has partnered with clients on microbial protein projects in the field of synthetic biology. In 2023, the company's microbial protein business, starting from scratch, successfully achieved industrialization of ton-level products.

Recommend

Copyright © Jiangxi Fushine Pharmaceutical Co., Ltd.. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |